Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
Imbalanced proteostasis is associated with diverse diseases, including ischemia/reperfusion injury in the heart. Here the authors show that the ATF6 arm of the unfolded protein response can be pharmacologically activated with a small molecule in vivo, providing protection from ischemia/reperfusion i...
Enregistré dans:
Auteurs principaux: | Erik A. Blackwood, Khalid Azizi, Donna J. Thuerauf, Ryan J. Paxman, Lars Plate, Jeffery W. Kelly, R. Luke Wiseman, Christopher C. Glembotski |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3ba71f4e4b844e449ec46f1e2075895f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cellular proteostasis decline in human senescence
par: Karli Montague-Cardoso
Publié: (2021) - Cellular reprogramming
-
Cellular sequestrases maintain basal Hsp70 capacity ensuring balanced proteostasis
par: Chi-ting Ho, et autres
Publié: (2019) -
ATF3 negatively regulates cellular antiviral signaling and autophagy in the absence of type I interferons
par: Vikas Sood, et autres
Publié: (2017) -
Neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation
par: Cristina Pintado, et autres
Publié: (2017)